158 related articles for article (PubMed ID: 23747587)
1. Immunomodulatory effects of nanocurcumin in arsenic-exposed rats.
Sankar P; Telang AG; Suresh S; Kesavan M; Kannan K; Kalaivanan R; Sarkar SN
Int Immunopharmacol; 2013 Sep; 17(1):65-70. PubMed ID: 23747587
[TBL] [Abstract][Full Text] [Related]
2. Effects of nanoparticle-encapsulated curcumin on arsenic-induced liver toxicity in rats.
Sankar P; Gopal Telang A; Kalaivanan R; Karunakaran V; Manikam K; Sarkar SN
Environ Toxicol; 2015; 30(6):628-37. PubMed ID: 24347089
[TBL] [Abstract][Full Text] [Related]
3. Oral nanoparticulate curcumin combating arsenic-induced oxidative damage in kidney and brain of rats.
Sankar P; Telang AG; Kalaivanan R; Karunakaran V; Suresh S; Kesavan M
Toxicol Ind Health; 2016 Mar; 32(3):410-21. PubMed ID: 24105067
[TBL] [Abstract][Full Text] [Related]
4. Protective action of curcumin and nano-curcumin against arsenic-induced genotoxicity in rats in vivo.
Sankar P; Telang AG; Ramya K; Vijayakaran K; Kesavan M; Sarkar SN
Mol Biol Rep; 2014 Nov; 41(11):7413-22. PubMed ID: 25078984
[TBL] [Abstract][Full Text] [Related]
5. PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms.
Xie X; Tao Q; Zou Y; Zhang F; Guo M; Wang Y; Wang H; Zhou Q; Yu S
J Agric Food Chem; 2011 Sep; 59(17):9280-9. PubMed ID: 21797282
[TBL] [Abstract][Full Text] [Related]
6. Purely aqueous PLGA nanoparticulate formulations of curcumin exhibit enhanced anticancer activity with dependence on the combination of the carrier.
Nair KL; Thulasidasan AK; Deepa G; Anto RJ; Kumar GS
Int J Pharm; 2012 Apr; 425(1-2):44-52. PubMed ID: 22266528
[TBL] [Abstract][Full Text] [Related]
7. Metabolic fate of poly-(lactic-co-glycolic acid)-based curcumin nanoparticles following oral administration.
Harigae T; Nakagawa K; Miyazawa T; Inoue N; Kimura F; Ikeda I; Miyazawa T
Int J Nanomedicine; 2016; 11():3009-22. PubMed ID: 27418823
[TBL] [Abstract][Full Text] [Related]
8. Curcumin encapsulated in chitosan nanoparticles: a novel strategy for the treatment of arsenic toxicity.
Yadav A; Lomash V; Samim M; Flora SJ
Chem Biol Interact; 2012 Jul; 199(1):49-61. PubMed ID: 22704994
[TBL] [Abstract][Full Text] [Related]
9. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells.
Yallapu MM; Gupta BK; Jaggi M; Chauhan SC
J Colloid Interface Sci; 2010 Nov; 351(1):19-29. PubMed ID: 20627257
[TBL] [Abstract][Full Text] [Related]
10. Photoprotective efficiency of PLGA-curcumin nanoparticles versus curcumin through the involvement of ERK/AKT pathway under ambient UV-R exposure in HaCaT cell line.
Chopra D; Ray L; Dwivedi A; Tiwari SK; Singh J; Singh KP; Kushwaha HN; Jahan S; Pandey A; Gupta SK; Chaturvedi RK; Pant AB; Ray RS; Gupta KC
Biomaterials; 2016 Apr; 84():25-41. PubMed ID: 26803409
[TBL] [Abstract][Full Text] [Related]
11. Poly(lactic-co-glycolic) acid loaded nano-insulin has greater potentials of combating arsenic induced hyperglycemia in mice: some novel findings.
Samadder A; Das J; Das S; De A; Saha SK; Bhattacharyya SS; Khuda-Bukhsh AR
Toxicol Appl Pharmacol; 2013 Feb; 267(1):57-73. PubMed ID: 23276653
[TBL] [Abstract][Full Text] [Related]
12. Poly(D,L-lactic acid)-glycerol-based nanoparticles for curcumin delivery.
Yoon IS; Park JH; Kang HJ; Choe JH; Goh MS; Kim DD; Cho HJ
Int J Pharm; 2015 Jul; 488(1-2):70-7. PubMed ID: 25900098
[TBL] [Abstract][Full Text] [Related]
13. Nanocurcumin ameliorates Staphylococcus aureus-induced mastitis in mouse by suppressing NF‑κB signaling and inflammation.
Suresh S; Sankar P; Telang AG; Kesavan M; Sarkar SN
Int Immunopharmacol; 2018 Dec; 65():408-412. PubMed ID: 30380516
[TBL] [Abstract][Full Text] [Related]
14. Perturbations in immune responses induced by concurrent subchronic exposure to arsenic and endosulfan.
Aggarwal M; Naraharisetti SB; Dandapat S; Degen GH; Malik JK
Toxicology; 2008 Sep; 251(1-3):51-60. PubMed ID: 18694802
[TBL] [Abstract][Full Text] [Related]
15. Microfluidic Assisted Nanoprecipitation of PLGA Nanoparticles for Curcumin Delivery to Leukemia Jurkat Cells.
Leung MHM; Shen AQ
Langmuir; 2018 Apr; 34(13):3961-3970. PubMed ID: 29544247
[TBL] [Abstract][Full Text] [Related]
16. Neuronal uptake and neuroprotective effect of curcumin-loaded PLGA nanoparticles on the human SK-N-SH cell line.
Doggui S; Sahni JK; Arseneault M; Dao L; Ramassamy C
J Alzheimers Dis; 2012; 30(2):377-92. PubMed ID: 22426019
[TBL] [Abstract][Full Text] [Related]
17. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
18. Orally administered nanocurcumin to attenuate morphine tolerance: comparison between negatively charged PLGA and partially and fully PEGylated nanoparticles.
Shen H; Hu X; Szymusiak M; Wang ZJ; Liu Y
Mol Pharm; 2013 Dec; 10(12):4546-51. PubMed ID: 24195658
[TBL] [Abstract][Full Text] [Related]
19. Curcumin-loaded PLGA-PEG-PLGA triblock copolymeric micelles: Preparation, pharmacokinetics and distribution in vivo.
Song Z; Feng R; Sun M; Guo C; Gao Y; Li L; Zhai G
J Colloid Interface Sci; 2011 Feb; 354(1):116-23. PubMed ID: 21044788
[TBL] [Abstract][Full Text] [Related]
20. Curcumin Nanoformulation for Cervical Cancer Treatment.
Zaman MS; Chauhan N; Yallapu MM; Gara RK; Maher DM; Kumari S; Sikander M; Khan S; Zafar N; Jaggi M; Chauhan SC
Sci Rep; 2016 Feb; 6():20051. PubMed ID: 26837852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
